Skip to content
Our Approach

Valuing every person, decision, and molecule within your research.

Individual diagnostics is at the heart of all we do. Our CLIA lab runs ultra-sensitive liquid biopsies to reveal actionable insight on a more personal level.

  • Why Sysmex Inostics?

    Sensitivity matters.

    We empower accurate detection of low-frequency biomarkers from a simple blood draw. Expedite your studies and uncover deeper insights into therapy response. Our testing technologies are optimized for ultra-sensitivity with high specificity and efficiency.

    Learn more

    Detect earlier

    Our ctDNA technology is optimized to ensure low-frequency mutant molecule detection (0.03-0.05%), giving physicians proactive insight into diagnosis and recurrence.

  • Why Sysmex Inostics?

    Sensitivity matters.

    We empower accurate detection of low-frequency biomarkers from a simple blood draw. Expedite your studies and uncover deeper insights into therapy response. Our testing technologies are optimized for ultra-sensitivity with high specificity and efficiency.

    Learn more

    Monitor easily

    Focused and flexible biomarker coverage allows quality data at reduced costs. With simple blood draws, we streamline testing over time, finding insight without invasion.

  • Why Sysmex Inostics?

    Sensitivity matters.

    We empower accurate detection of low-frequency biomarkers from a simple blood draw. Expedite your studies and uncover deeper insights into therapy response. Our testing technologies are optimized for ultra-sensitivity with high specificity and efficiency.

    Learn more

    Partner
    confidently

    We customize our testing for partners like you to unlock novel clinically relevant biomarker discoveries. We aren't just your testing lab — we are here to support throughout your whole research to CDx journey.

Our commitment

We fight for every patient’s life potential.

We are tired of diagnosis defining people’s livelihood, so we propel our knowledge forward to inform effective treatment — helping patients live their lives better for longer.

We began with a dream of individualized diagnostics and a wild invention—liquid biopsy. That discovery ignited our mission to leverage liquid insights in the body to transform research on a more personal, individual level.

Today, we call ourselves inexhaustible explorers. Because when we see the odds, we don’t stop until we beat them. We aren’t just fighting disease. We’re fighting for human futures.

Located on the Johns Hopkins Medical Campus, we have played a leading role in the fight against cancers since our inception in 2008 and as a CLIA lab for the last 10 years. While serving the pharmaceutical, clinical, and research communities, we have played a significant role in solid tumor cancer and AML discoveries. Currently, we're exploring how medicine manages HPV-driven head and neck cancer patients. And we’re just getting started.

Contact

We’d love to hear from you!

Hidden
Hidden
Hidden
Hidden
Hidden
Hidden